About Biota
Biota is a Healthcare company based in San Diego (United States) founded in 2013, and was acquired by Novozymes in March 2021. Environmental genomics services are delivered to the petroleum industry. The company has 126 employees. Its focus areas include Life Sciences, Genomics, Applied Genomics and Other Applications. Its legal entity is BIOTAGE, LLC. Its competitors include Synvect, BaseTrace and Integrated Lipid Biofuels; 2 of its 3 listed competitors have raised funding.
Company details
Biota is an environmental genomics company that uses DNA sequencing and data science to help oil companies maximize production from wells. The companys genomics-driven approach provides oil companies with data for identification of sweet spots for targeted stimulation, estimate well placement, measure production over time, and well connectivity to develop fields. The company performs shotgun sequencing using NGS of DNA from the subsurface to profile the microbial diversity and uses their proprietary analysis pipelines to provide actionable inputs to clients. Since the approach uses environmental DNA and requires no special equipment or procedure to collect samples, it is sustainable, economical, and convenient. The company is supported by Energy Innovation Capital, Xseed, and Illumina.
Funding Insights of Biota
- Total Rounds 2
- First Round $748,559
(Aug 2015)
- Investors Count 2
All 2 funding rounds of Biota with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2017 | Series B | – | Illumina Ventures | – | |
| Aug 2015 | $748,559 | Grant | – | – |
3 investors in total: 3 institutional.
Investors in Biota
Biota has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Novozymes, Illumina Ventures and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Health tech startups are invested in by Illumina Ventures. | illuminaventures.com | Foster City, United States | ||
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States | |
Biosolutions and enzymes are developed for biotechnology applications across industries. | 2000 | novozymes.com | Bagsvaerd, Denmark |
Investor details for Biota
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Biota
7 people are tracked at Biota (3 in leadership, 2 in board & advisors, 2 in team); the tracked headcount is 126.
| Name | Role | Group |
|---|---|---|
Daniel Triunfo | COO | Leadership |
Rob Knight | Technical Co-founder | Leadership |
Vik Rao | Chief Scientist | Leadership |
Thomas Ishoey | Industrial Genomics Advisor | Board & advisors |
Shandell Szabo | Chairman | Board & advisors |
Julio Guzman | Associate Scientist | Team |
Matthew Haggerty | Senior Data Scientist | Team |
Complete people profiles for Biota
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Biota
4 dated milestones of Biota across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Biota is founded.
- Funding First funding round of $749K.
- Funding Latest funding round, Series B,.
- Exit Acquired by Novozymes.
Competitors of Biota
Biota has 3 listed competitors in our database, 2 of them funded. They include Synvect, BaseTrace and Integrated Lipid Biofuels.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| synvect.com | 2022 | San Diego, United States | $3M | CRISPR-based mosquito control solutions are developed for disease reduction. | ||
| basetrace.com | 2012 | Durham, United States | $20,000 | Provides DNA-based tracing solutions for effective environmental monitoring and analysis. | ||
| ilbllc.com | 2018 | Pullman, United States | Develops innovative biopolymer technologies to produce sustainable biofuel feedstocks. |
Detailed competitors of Biota
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Biota (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biota
Complete news archive for Biota
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biota
Biota was founded in 2013 and raised its 1st funding round 2 years after it was founded.
Biota is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Biota has 126 employees.
Biota is an environmental genomics company that uses DNA sequencing and data science to help oil companies maximize production from wells. The companys genomics-driven approach provides oil companies with data for identification of sweet spots for targeted stimulation, estimate well placement, measure production over time, and well connectivity to develop fields. The company performs shotgun sequencing using NGS of DNA from the subsurface to profile the microbial diversity and uses their proprietary analysis pipelines to provide actionable inputs to clients. Since the approach uses environmental DNA and requires no special equipment or procedure to collect samples, it is sustainable, economical, and convenient. The company is supported by Energy Innovation Capital, Xseed, and Illumina.
Biota's top competitors include Synvect, BaseTrace and Integrated Lipid Biofuels.
Biota has 3 investors. Key investors include Novozymes, Illumina Ventures, and National Science Foundation.
Biota operates through Biotage, Llc.
Yes. Biota was acquired by Novozymes in March 2021.